BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28698985)

  • 1. A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.
    Fauvelle C; Lambotin M; Heydmann L; Prakash E; Bhaskaran S; Vishwaraman M; Baumert TF; Moog C
    Hepatol Int; 2017 Sep; 11(5):440-445. PubMed ID: 28698985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
    Li S; Kodama EN; Inoue Y; Tani H; Matsuura Y; Zhang J; Tanaka T; Hattori T
    Antivir Chem Chemother; 2010 Aug; 20(6):239-48. PubMed ID: 20710064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.
    Connell BJ; Chang SY; Prakash E; Yousfi R; Mohan V; Posch W; Wilflingseder D; Moog C; Kodama EN; Clayette P; Lortat-Jacob H
    PLoS One; 2016; 11(10):e0165386. PubMed ID: 27788205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.
    Chowdhury P; Sahuc ME; Rouillé Y; Rivière C; Bonneau N; Vandeputte A; Brodin P; Goswami M; Bandyopadhyay T; Dubuisson J; Séron K
    PLoS One; 2018; 13(11):e0198226. PubMed ID: 30485282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry.
    Behrendt P; Perin P; Menzel N; Banda D; Pfaender S; Alves MP; Thiel V; Meuleman P; Colpitts CC; Schang LM; Vondran FWR; Anggakusuma ; Manns MP; Steinmann E; Pietschmann T
    Antiviral Res; 2017 Nov; 147():19-28. PubMed ID: 28923507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.
    Colpitts CC; Baumert TF
    Hepatol Int; 2016 Sep; 10(5):741-8. PubMed ID: 27048616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
    Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
    J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin.
    Tawar RG; Heydmann L; Bach C; Schüttrumpf J; Chavan S; King BJ; McClure CP; Ball JK; Pessaux P; Habersetzer F; Bartenschlager R; Zeisel MB; Baumert TF
    Hepatology; 2016 Nov; 64(5):1495-1506. PubMed ID: 27531416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry inhibitors: New advances in HCV treatment.
    Qian XJ; Zhu YZ; Zhao P; Qi ZT
    Emerg Microbes Infect; 2016 Jan; 5(1):e3. PubMed ID: 26733381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of Cinnamon Blocks Leukocyte Attachment by Interacting with Sialosides.
    Lin WL; Guu SY; Tsai CC; Prakash E; Viswaraman M; Chen HB; Chang CF
    PLoS One; 2015; 10(6):e0130389. PubMed ID: 26076445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.
    Koutsoudakis G; Romero-Brey I; Berger C; Pérez-Vilaró G; Monteiro Perin P; Vondran FW; Kalesse M; Harmrolfs K; Müller R; Martinez JP; Pietschmann T; Bartenschlager R; Brönstrup M; Meyerhans A; Díez J
    J Hepatol; 2015 Oct; 63(4):813-21. PubMed ID: 26070407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.